Search the Newsreel

Weyerhaeuser (WY) Could Be 18% Undervalued After Stronger Second Quarter Earnings

Weyerhaeuser (WY) recently reported strong second-quarter 2026 earnings, with net income of US$162 million and earnings per share of US$0.23, leading to short-term stock gains. Despite these positive developments, Simply Wall St suggests the stock could still be 18% undervalued, with a fair value …

Earnings Preview: HawkEye 360 to Report Financial Results Post-market on August 13

This article announces that HawkEye 360 will report its financial results post-market on August 13. It is an earnings preview indicating an upcoming financial disclosure by the company.

Keyera Corp. (KEY) Receives a Rating Update from a Top Analyst

Dimensional Fund Advisors LP Has $19.50 Million Stock Holdings in Mobileye Global Inc. $MBLY

Weyerhaeuser (WY) Could Be 18% Undervalued On Its Latest Earnings Beat

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Weyerhaeuser (WY) is back in focus after reporting second quarter 2026 net income of …

Weyerhaeuser (WY) Q2 2026 Earnings Call Transcript

Eyepoint Pharmaceuticals' (EYPT) "Buy" Rating Reiterated at Chardan Capital

Chardan Capital has reiterated its "Buy" rating for Eyepoint Pharmaceuticals (NASDAQ:EYPT) and set a $65 price target, indicating a potential upside of over 400%. Despite a recent quarterly loss that missed analyst estimates, the company's revenue exceeded expectations, and institutional investors hold a significant …

AEye (NASDAQ:LIDR) Posts Earnings Results, Hits Estimates

RBC Capital Keeps Their Buy Rating on EyePoint Pharmaceuticals (EYPT)

RBC Capital analyst Lisa Walter reiterated a Buy rating for EyePoint Pharmaceuticals (EYPT) with a price target of $37.00. This comes despite a GAAP net loss of $84.83 million in the latest quarter and negative insider sentiment with increased selling of shares. H.C. Wainwright …

WY Q2 Beat Shows a Lumber Rebound but Higher OSB Costs Cloud Outlook

Weyerhaeuser (WY) reported a stronger-than-expected Q2 earnings beat, driven by improvements in lumber and engineered wood products. However, the recovery was not broad-based, with higher oriented strand board (OSB) costs and weaker contributions from other segments impacting the overall outlook. The company's Q3 guidance …

WY Stock Jumps 13.1% in a Month: Can the Rally Keep Gaining Ground?

Weyerhaeuser Company WY shares have gained 13.1% in the past four weeks, putting the durability of the move in focus. The advance has coincided with a second-quarter 2026 earnings beat and a sequential recovery in Wood Products. The setup is not one-directional. Housing remains …

AudioEye Inc (AEYE) Earnings Forecast: Future EPS & Revenue Growth Estimates

AudioEye Inc (AEYE) has an earnings forecast score of 7.50, ranking 238 out of 483 in its industry, with an average price target of $22.00 from analysts. Four analysts currently rate the stock as a "Buy" with a significant upside potential of 172.49%. The …

Weyerhaeuser Company (NYSE:WY) Given Consensus Rating of "Moderate Buy" by Brokerages

Weyerhaeuser Company (NYSE:WY) has received a "Moderate Buy" consensus rating from eleven brokerages, with an average 12-month price target of $29.00. The company recently reported Q2 earnings of $0.13 EPS on $1.87 billion revenue, exceeding analyst estimates despite an 8.3% year-over-year revenue decline. Weyerhaeuser …

AEye Inc (LIDR) Stock News Today

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Given New $55.00 Price Target at Cantor Fitzgerald

Cantor Fitzgerald has increased its price target for Eyepoint Pharmaceuticals (NASDAQ:EYPT) to $55.00 from $47.00, maintaining an "overweight" rating and suggesting a substantial upside. This new target is part of generally positive analyst sentiment, even as the company recently reported a quarterly EPS loss …

Transcript : Keyera Corp., Q2 2026 Earnings Call, Aug 06, 2026

AEYE|AudioEye Inc|Price:6.000|Chg%:+0.220

AEye (LIDR) Q2 2026 Earnings Call Transcript

Innovative Eyewear Inc (LUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Innovative Eyewear Inc (LUCY), detailing its current earnings forecast score, price target, and analyst ratings. Based on one analyst, the stock has a "Hold" rating with a target price of $3.00. The company's expected revenue for the …

EYPT Maintained by Cantor Fitzgerald -- Price Target Raised to $55

Cantor Fitzgerald maintained an Overweight rating for EyePoint Pharmaceuticals (EYPT) and raised its price target from $47.00 to $55.00, signaling a positive outlook despite the company's current overvaluation according to GuruFocus. EYPT's GF Value™ indicates it is significantly overvalued at $0.69 compared to its …

Wellington group discloses 8.34M EYE shares in National Vision (EYE) filing

Wellington Management Group LLP and its affiliated entities have reported a beneficial ownership of 8,338,927 shares in National Vision Holdings, Inc. (EYE), which represents 10.41% of the company's outstanding common stock. The filing, a Schedule 13G/A, indicates that while the Wellington entities hold significant …

EyePoint, Inc. (EYPT) Stock Price, News, Quote & History

This article provides a comprehensive overview of EyePoint, Inc. (EYPT), a biotechnology company specializing in therapeutics for retinal diseases. It includes current stock price, historical performance data, key financial metrics, and analyst ratings. The company is developing treatments like DURAVYU and EYP-2301, leveraging its …

FMR LLC discloses 5.1% National Vision (EYE) holding in Schedule 13G

FMR LLC has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in National Vision Holdings, Inc. (EYE), totaling 4,070,391.74 shares of common stock as of June 30, 2026. The filing indicates that FMR LLC holds sole voting power over 4,048,604.00 shares and …

Analysts Offer Insights on NA Companies: Versigent Limited (VGNT), SpaceX (SPCX) and Circle Internet Group, Inc. Class A (CRCL)

This article highlights bullish sentiments from analysts on three NA sector companies: Versigent Limited (VGNT), SpaceX (SPCX), and Circle Internet Group, Inc. Class A (CRCL). Morgan Stanley and RBC Capital maintained Buy ratings for Versigent, Wolfe Research reiterated a Buy for SpaceX, and William …

Mobileye Director Frank Yeary Buys 12,360 Shares After 43% Stock Decline. Should Investors Be Excited for the Rest of 2026?

Mobileye Director Frank D. Yeary recently purchased 12,360 shares of the company's Class A Common Stock for approximately $98,600, increasing his total equity position by 16%. This acquisition occurred after a 43% stock decline over the past year, signaling a positive outlook from the …

Keyera Announces 2026 Second Quarter Results

CALGARY, AB, Aug. 6, 2026 /CNW/ -- Keyera Corp. (TSX: KEY) ("Keyera", the "company" or "our") today announced its results for the second quarter ended June 30, 2026. To view our Management's Discussion and Analysis (the "MD&A") and financial statements, visit either Keyera's website …

The Bull Case For Weyerhaeuser (WY) Could Change Following Sharply Higher First-Half 2026 Profitability

Weyerhaeuser (WY) reported a significant increase in net income for the second quarter and first half of 2026, with Q2 net income rising to US$162 million and first-half net income almost doubling to US$318 million. This improved profitability strengthens the company's near-term earnings picture …

HawkEye 360 (NYSE:HAWK) - Stock Analysis

This report provides an in-depth stock analysis of HawkEye 360 (NYSE:HAWK), a space-enabled defense technology company. The analysis covers the company's valuation, future growth prospects, past performance, financial health, dividends, management, and ownership, alongside recent news and analyst ratings. Despite recent operational wins and …

AEye (Nasdaq: LIDR) Q2 revenue jumps nine-fold while net losses remain high

HC Wainwright Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Announces Quarterly Earnings Results

Keyera (KEY) Earnings Date and Reports 2026 $KEY

Weyerhaeuser Company Stock: Is Wall Street Bullish or Bearish?

Weyerhaeuser Raymond Lumber site with logo By IanDewarPhotography Weyerhaeuser Company (WY) is one of the world's largest private owners of timberlands and a leading real estate investment trust (REIT) focused on sustainable forest management and wood products manufacturing. Weyerhaeuser produces a wide range of …

Kits Eyecare (TSX:KITS) Stock Can Profit Growth Justify An 87.1x P/E

Ahead‑of‑Schedule DME Trial Enrollment Could Be A Game Changer For EyePoint (EYPT)

EyePoint Pharmaceuticals has completed enrollment ahead of schedule for its Phase 3 trials of DURAVYU for diabetic macular edema (DME), enrolling over 480 patients in five months. This rapid enrollment, coupled with prior safety data and regulatory alignment, positions DURAVYU as a potential long-acting …

Keyera Increases Quarterly Dividend by 4.17% and Announces Third Quarter Distribution

CALGARY, AB, Aug. 5, 2026 /CNW/ -- Keyera Corp. (TSX: KEY) ("Keyera") announced today it is increasing its quarterly cash dividend per common share by 4.17% from $0.54 to $0.5625, or $2.25 annually. The dividend payment for the third quarter of 2026 will be …